全部照片(1)

文件

35485

2,4′-DDD

Name: 2,4′-DDD
Brand: SIAL

PESTANAL^®, analytical standard

同義詞:

1-(2-氯苯基)-1-(4-氯苯基)-2,2-二氯乙烷, o,p′-DDD, 氯苯二氯乙烷, 米托坦

登入查看組織和合約定價

全部照片(1)

About This Item

線性公式:

(ClC₆H₄)₂CHCHCl₂

CAS號碼:

53-19-0

分子量：:

320.04

Beilstein:

2056007

EC號碼:

200-166-6

分類程式碼代碼:

41116107

PubChem物質ID:

329755170

NACRES:

NA.24

推薦產品

Slide 1 of 10

1 of 10

Supelco

36663

2,4′-DDE 溶液

Supelco

35486

4,4′-DDD

Supelco

45839

2,4′-DDT 溶液

Supelco

49018

2,4′-DDT

Supelco

35487

4,4'-DDE

Supelco

31041

4,4′-滴滴涕

Supelco

40124

4,4′-DDT 溶液

Supelco

32758

玉米烯酮-¹³C₁₈ 溶液

Supelco

45522

六氯苯

Supelco

44012

1-(2-氯苯基)-1-(4-氯苯基)-2,2-二氯乙烷

等級

analytical standard

品質等級

100

產品線

PESTANAL^®

儲存期限

limited shelf life, expiry date on the label

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

agriculture
environmental

格式

neat

SMILES 字串

ClC(Cl)C(c1ccc(Cl)cc1)c2ccccc2Cl

InChI

1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H

InChI 密鑰

JWBOIMRXGHLCPP-UHFFFAOYSA-N

基因資訊

human ... CYP11A1(1583) , CYP11B1(1584)

尋找類似的產品？前往產品比較指南

一般說明

2,4′-DDD is generally used to reduce the endogenous CORT neuropeptide, which might mask the total population of intracellular corticosteroid receptors in sparrows. It is an adrenal specific agent, which can find potent applications in the treatment of adrenocortical carcinoma (ACC).

應用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

法律資訊

PESTANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

象形圖

GHS08

訊號詞

Warning

危險聲明

H351

防範說明

P201 - P202 - P280 - P308 + P313 - P405 - P501

危險分類

Carc. 2

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

分析證明 (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

Slide 1 of 1

1 of 1

Supelco

34021

4,4′-DDT-d₈

Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients

Haak.R.H, et al.

British Journal of Cancer, 69(5), 947-951 (1994)

Pharmacological characterization of intracellular, membrane, and plasma binding sites for corticosterone in house sparrows

Breuner.WC and Orchinik M

General and Comparative Endocrinology, 163(1), 214-224 (2009)

Mitotane for adrenocortical carcinoma treatment

SH and MF

Current Opinion in Investigational Drugs, 6(4), 386-394 (2005)

Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial.

Matthias Kroiss et al.

The Journal of clinical endocrinology and metabolism, 97(10), 3495-3503 (2012-07-28)

Treatment of refractory adrenocortical carcinoma (ACC) is not established. Animal experiments pointed toward adrenal toxicity of sunitinib. The objective of the study was to determine the antitumor effects of sunitinib in refractory ACC. This was a phase II, open-label trial

Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement.

Vasileios Chortis et al.

The Journal of clinical endocrinology and metabolism, 98(1), 161-171 (2012-11-20)

Mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane] is the first-line treatment for metastatic adrenocortical carcinoma (ACC) and is also regularly used in the adjuvant setting after presumed complete removal of the primary tumor. Mitotane is considered an adrenolytic substance, but there is limited information on

查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務

文件

2,4′-DDD